British pharmaceutical giant AstraZeneca says its vaccine is showing promising results in protecting those groups that are most at risk from the new coronavirus.
Being developed in collaboration with the University of Oxford, the vaccine shows a strong immune response in those aged above 70 in its Phase 2 trials.
The positive news on the vaccine front comes as cases continue to rise.
Al Jazeera's Charlie Angela reports.
- Subscribe to our channel: http://aje.io/AJSubscribe
- Follow us on Twitter: https://twitter.com/AJEnglish
- Find us on Facebook: https://www.facebook.com/aljazeera
- Check our website: https://www.aljazeera.com/
#AlJazeeraEnglish #Coronavirus #COVID-19
Being developed in collaboration with the University of Oxford, the vaccine shows a strong immune response in those aged above 70 in its Phase 2 trials.
The positive news on the vaccine front comes as cases continue to rise.
Al Jazeera's Charlie Angela reports.
- Subscribe to our channel: http://aje.io/AJSubscribe
- Follow us on Twitter: https://twitter.com/AJEnglish
- Find us on Facebook: https://www.facebook.com/aljazeera
- Check our website: https://www.aljazeera.com/
#AlJazeeraEnglish #Coronavirus #COVID-19
- Category
- World
- Tags
- uk covid-19 human trials, coronavirus news, aljazeera
Sign in or sign up to post comments.
Be the first to comment